Pregnancy Hypertension-An International Journal of Womens Cardiovascul

Article	Citations
PO1_20. Midtrimester drop in bp is not associated with a decreased risk for hypertensive disorder of pregnancy in a nulliparous cohort	476
PO6_15. Predictive utility for preeclampsia of the SFLT-1/PLGF ratio test in routine clinical practice: a retrospective analysis of 1,397 pregnancies with suspected pre-eclampsia	116
PO6_19. The diagnostic accuracy of American college of cardiology/American heart association blood pressure categories for identification of women and babies at risk of adverse pregnancy outcomes – a	46
PO8_1. CANCELLED : Predictive value of longitudinal maternal serum angiogenic marker assessment for maternal adverse outcomes in pregnancies with preeclampsia	42
OP14_5. Metformin to prolong pregnancy in preterm preeclampsia	39
OP15_4. A biopolymer-fused form of placental growth factor for treatment of preeclampsia	29
O-001. Acute cardiovascular and hemodynamic consequences of placental growth factor administration in guinea pigs	27
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to lett	24
PS-1. Future interaction among International Society of Hypertension (ISH), Japan Society of Hypertension (JSH) and ISSHP	20
Exploring proteomics in the search of novel predictive cardiovascular biomarkers for preeclampsia	19
P-002. Evidence of neuroinflammation and injured blood–brain-barrier in eclampsia	19
Sociodemographic risk factors associated with patient follow-up after implementation of a CardioObstetrics program	18
GSTP1-A313G genetic polymorphism and the risk of preeclampsia in pregnant women: A study in the northern population of Iran	17
Comparison of subfoveal choroidal thickness in patients with hypertensive disorder of pregnancy versus normotensive pregnant women in third trimester of pregnancy	17
Six-week blood pressure trends in postpartum patients utilizing remote patient monitoring program	17
Examining changes in clinical management and postpartum readmissions for hypertensive disorders of pregnancy over time	17
Comprehensive transcriptome mining identified the gene expression signature and differentially regulated pathways of the late-onset preeclampsia	16
Comparison of Zuspan regimen and its 12-hour modification in women with severe pre-eclampsia and eclampsia in two hospitals in Abeokuta	16
Perceptions and experiences of blood pressure self-monitoring during hypertensive pregnancy: A qualitative analysis of women’s and clinicians’ experiences in the OPTIMUM-BP trial	16
Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia – A qualitative study	15
New 3D cardiac in vitro models for assessing the maternal cardiovascular health five years post hypertensive disorders of pregnancy	14
Dietary protein source contributes to the risk of developing maternal syndrome in the Dahl salt-sensitive rat	14
Prevalence of hypertensive disorders in pregnancy in China: A systematic review and meta-analysis	13
Reduced urinary angiotensinogen excretion in preeclampsia	13
Alterations in the metabolic status of amino acids in newborns of pre-eclampsia women	13

PO2_08. decreased sodium (NA + ) buffer capacity in pregnancy and in women following pre-eclampsia	13
How digital health affects the patient-physician relationship: An empirical-ethics study into the perspectives and experiences in obstetric care	13
Current state of affairs: A study regarding diagnosis, treatment and use of home blood pressure monitoring for hypertension in pregnancy	13
Response to letter to the editor	12
PO7_3. Patient perception of home blood pressure monitoring kits	12
P-097. Exploring education preferences of Australian women and healthcare providers regarding long-term health after hypertensive disorders of pregnancy – A qualitative rerspective	12
P-059. Prevalence and risk analysis of early-onset and late-onset of hypertensive disorders of pregnancy	12
Short communication: Is there any benefit of initiating aspirin before the 11th week of gestation?	11
Association of MTHFR C677T and A1298C variants with preeclampsia risk and angiogenic imbalance in Tunisian women	11
Conformation-dependent anti-Aβ monoclonal antibody signatures of disease status and severity in urine of women with preeclampsia	11
Impact of maternal hypertensive disorders of pregnancy on brain volumes at term-equivalent age in preterm infants: A voxel-based morphometry study	11
Extended postpartum outcomes with systematic treatment of and management of postpartum hypertension program	11
Diagnostic accuracy of urine dipstick tests for proteinuria in pregnant women suspected of preeclampsia: A systematic review and meta-analysis	10
Management of hypertension in the early postpartum: A randomized controlled trial	10
The sFLT-1/PlGF ratio versus biochemical parameters in prediction of adverse outcomes in preeclamptic women	10
SY3-1. Long-term consequences of pregnancy complications: lessons from mouse models	9
P-023. Uterine vascular resistance and other maternal factors associated with the risk of developing hypertension during pregnancy	9
Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia	9
WITHDRAWN: COVID-19 not hypertension or diabetes increases the risk of preeclampsia among a high-risk population	9
P-050. Potency of Tokishakuyakusan in treating preeclampsia: Drug repositioning method by in vitro screening of the Kampo library	9
Re: Vascular endothelial growth factor C/A 2578 gene polymorphism and umbilical artery doppler in preeclamptic women. Mowad HH, Abougabal KM, Fahim AS, Shehata NAA, Ali HAA, Nasser MZ. Pregnancy Hyper	9
Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study	9
P-026. Association between vascular remodeling biomarkers and the placentary bed in pre-eclampsy	9
Letter to the editor: Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	9
Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia	9
OP14_4. Epigenetic regulation by STOX1 in trophoblast cells lines	8
O-005. Circulating biomarkers for neurological complications in preeclampsia	8
P-104. Clinical characteristics and sequelae of intrapartum hypertension	8
PO4_2. Genome-wide association study sheds more light on the pathophysiology of preeclampsia	8
PO7_1. Patient perceptions regarding remote patient monitoring for postpartum hypertension	8
SY5-1. Timing of delivery in late preterm pre-eclampsia	8
SY2-3. The role of autophagy in pathophysiology of PE	8
PO9_05. Endothelial glycocalyx dysfunction in early- and late-onset preeclampsia	8
Perinatal outcomes and their determinants among women with eclampsia and severe preeclampsia in selected tertiary hospitals, Eastern Ethiopia	8
GS-4. Epidemiology of preeclampsia	8
P-017. The Elecsys sFlt-1/PlGF ratio for short-term prediction of preeclampsia in the Japanese cohort of the PROGNOSIS Asia study: Economic evaluation	8
Rubidium – Initial observations of an enigmatic element in pre-eclampsia	7
Validation of urinary Congo Red preeclampsia detection point-of-care devise	7
Effect of positioning on blood pressure measurement in pregnancy	7
Exposure to higher concentrations of exogenous ELABELA causes HTR-8/SVneo trophoblast cell dysfunction: A possible pathogenesis of pre-eclampsia	7
Proteinuria in severe preeclampsia: Clinical significance in modern obstetrics	7
Neuroimaging in eclampsia: A window into the correlates between neural pathology and maternal outcomes	7
Angiogenic factors and prediction for ischemic placental disease in future pregnancies	7
History of IgA vasculitis with nephropathy (Henoch-Schonlein purpura nephritis) can be a strong risk factor for preeclampsia	7
Case of chorioamnionitis in ANA positive in second trimester of pregnancy	7
Association between serum NfL and NfH with Antepartum and Postpartum Hypertension	7
Smaller decrease in late second trimester blood pressure is associated with gestational hypertensive disease development	7
Congo red dot test in the early prediction and diagnosis of pre-eclampsia in a tertiary health care centre in India	7
Home blood pressure monitoring and mobile health application practices among pregnant persons with and at risk of hypertensive disorders of pregnancy	7
P-009. Associations between circulating sFlt-1 and PlGF and preeclampsia with severe maternal complications, or eclampsia	6

P-103. Incidence and clinical characteristics of hypotension in pregnancy	6
PO3_09. Inhibition of arginase and supplementation with folic acid decrease ROS production in endothelial cells incubated with plasma from preeclampsia pregnant	6
PO7_4. Short animated videos aimed at the greatest number of women, to allow and promote self-care in preeclampsia	6
Secondary hyperaldosteronism due to renal agenesis: Rare cause of secondary hypertension in pregnancy	6
P-034. Decreased circulating levels of plasmacytoid dendritic cells in women with early-onset preeclampsia	6
PO6_06. Soluble endoglin versus SFLT-1/PLGF ratio: detection of preeclampsia, hellp syndrome and FGR in a high-risk cohort	6
PO3_11. Elective anticipation of delivery in preeclampsia with cervical preparation by prostaglandins: success for vaginal delivery	6
PO2_07. Metabolic outcomes in women six months and two years after hypertensive versus normotensive pregnancy – a P4 study	6
Maternal bradycardia heralding deteriorating HELLP syndrome (pregnancy hypertension)	6
Y-004. Investigating nitrate metabolism and the oral microbiome in hypertensive pregnancies	6
PO2_14. Impact of previous hypertensive disorders during pregnancy on long-term cardiovascular consequences in women with severe hypertension	6
PO6_21. The utility of the SFLT-1/PLGF ratio among patients with or without hypertension who are suspected of having preeclampsia	6
SY4-4. Role of sFlt-1 on the development of preeclampsia: basic and clinical approach	6
Perfluorooctane sulfonic acid increases blood pressure and disrupts vascular function and placental steroidogenesis in pregnant rats	5
Comparison of double-filtration plasmapheresis (DFPP) versus heparin-mediated extracorporeal LDL-precipitation (HELP)-apheresis in early-onset preeclampsia	5
PO8_4. Late postpartum eclampsia with multifocal posterior reversible encephalopathy syndrome after twin gestation: a case report	5
OP08_2. New generation antiplatelet therapies decrease soluble FMS-like tyrosine kinase-1, enhance antioxidant cytoprotection, rescue vascular and endothelial dysfunction and decrease hypertension in	5
Novel electronic health records applied for prediction of pre-eclampsia: Machine-learning algorithms	5
Determining the relationship between severity of proteinuria and adverse maternal and neonatal outcomes in patients with preeclampsia	5
PO9_13. Towards ‘the best method to determine proteinuria’ in pregnant women	5
Nifedipine outperforms labetalol: A comparative analysis of hypertension management in black pregnancies	5
PLGF – A pioneer in prediction of pre - eclampsia	5
PO1_03. Individual, social, and environmental risk factors for hypertensive disorders of pregnancy in Ghana: A systematic review	5
PO1_04. Innovative use of Robson classification to understand prevalence of preeclampsia: findings from a Brazilian survey	5
Corrigendum to “Down-regulation of B2R contributes to preeclampsia by inhibiting human trophoblast cell invasion and angiogenesis” [Pregnancy Hypertens. 21 (2020) 14–22]	5
Validation of the Finnish Care register for Health Care diagnoses for preeclampsia, gestational diabetes and preterm delivery	5
OP04_5. Risk for cardiovascular and cerebrovascular diseases in women during first ten years after pre-eclampsia pregnancy in the FINNPEC study	5
PO6_20. The SFLT-1/PLGF ratio for the prediction of preeclampsia-related adverse fetal and maternal outcomes in women with preexisting diabetes	5
Impact of antenatal SARS-CoV-2 infection on development of hypertensive disorders of pregnancy in a large, diverse, cohort	4
Editorial Board	4
Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-contr	4
SY1-2. COMT in the biology of preeclampsia	4
Assessing the Mediterranean diet adherence during pregnancy: Practical considerations based on the associations with cardiometabolic risk	4
P-056. Profound changes in hemodynamics proving late-onset PE being of maternal origin	4
Signs or symptoms of suspected preeclampsia – A retrospective national database study of prevalence, costs, and outcomes	4
P-088. Aspirin and the risk of birthing a small for gestational age infant; A Swedish population-based study	4
SY6-2. Possible role of statin to prevent preeclampsia	4
Uterine artery Doppler for the prediction of outcome in pregnancies complicated by hypertensive disorders of pregnancy	4
SY5-3. Maternal mortality: how can lives are saved?	4
P-106. COVID-19 and pre-eclampsia: a literature review	4
Editorial Board	4
Women’s perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia	4
Reference-range of arterial stiffness by cardio-ankle vascular index in normal pregnancy	4
Preeclampsia and eclampsia: Its burden and distribution across facilities in Ethiopia	4
P-035. Behavioral risk factors of cardiovascular diseases in pregnant women. Prevalence and socioeconomic predictors in Burkina Faso: a cross-sectional study	4
Improving compliance with guidelines for hypertensive disorders of pregnancy through an electronic health record alert: A retrospective chart review	4
Barriers and facilitators for adequate calcium intake during pregnancy: A mixed methods study	4
Low physical activity levels 1 year after pregnancy complications	4
Welcome Message by Congress Chair of ISSHP 2021	4
P-031. Vitamin D maintains viability and decreases apoptosis in huvec and modulates inflammation in placenta from preeclamptic women cultured with TNF-α	4
Persistence of abnormal uterine artery flow postpartum: Case-control study	4
Increased adherence to ACOG diagnostic guidelines for HDP following a workshop in Bolivia, a LMIC	4
PO1_16. Changes in early pregnancy blood pressure among nulliparas that developed a hypertensive disorder of pregnancy	4
OP15_5. Metformin to treat preeclampsia: mechanism of action influences mitochondrial dynamics	4
Improving treatment of severe hypertension in pregnancy and postpartum using a hypertensive pathway	3
Cardiovascular morbidity and mortality following hypertensive disorders of pregnancy	3
Preeclampsia in women with lupus – Influence of aspirin and hydroxychloroquine on pregnancy outcome	3
SY2-1. Enhanced adenosine signaling in the placenta: a crucial pathogenic factor and a possible therapeutic target for preeclampsia	3
A study of long-term prognosis after delivery in patients with hypertensive disorders of pregnancy	3
A multi-ancestry genome-wide association study identifies novel candidate loci near the RARB gene associated with hypertensive disorders of pregnancy in the personalized environment and genes study	3
OP05_5. Characterization of prokineticins receptors anatagonization in preeclampsia: in vitro and in vivo studies	3
PO8_3. Investigating the role of biomarkers (SFLT-1/PLGF) in cases of covid-19 and its use to distinguish preeclampsia and guide clinical management	3
Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease	3
SC3_3. FKBPL signalling in placental development and preeclampsia	3
Risk factors of preeclampsia among pregnant women admitted at labor ward of public hospitals, low income country of Ethiopia; case control study	3
Circulating Activin A is elevated at 36 weeks’ gestation preceding a diagnosis of preeclampsia	3
Y-017. SAFE@HOME: Digital health platform facilitating a new care path for women at increased risk of preeclampsia – A case-control study	3
Is a sFlt-1/PlGF cutoff of 38 suitable to predict adverse outcomes in pregnancies with abnormal uterine artery Doppler velocimetry in the second trimester?	3
Impact of Maternal Early Warning Trigger (MEWT) tool on the incidence of eclampsia	3
Eplerenone: A candidate drug to mitigate long-term maternal vascular dysfunction following preeclampsia	3
Residual liver stiffness in the postpartum period in women with preeclampsia and healthy women: A case-control study	3
PO3_10. CANCELLED : A randomized controlled trial comparing low doses of aspirin in the prevention of preeclampsia (ASAPP): the first 100 patients	3
Maternal pulmonary hypertension and cardiopulmonary outcomes during delivery hospitalization in the United States: A nationwide study from 2016–2020	3
The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre study	3
Analyses of selected tumour-associated factors expression in normotensive and preeclamptic placenta	3
SY10-2. Management of severe postpartum TMA	3
Y-016. Interaction between previous preeclampsia and inter-pregnancy chronic hypertension development on preeclampsia risk in the subsequent pregnancy	3
PO1_19. Maternal Mortality from Hypertension in Pregnancy in Brazil from 2015 to 2019	3
Association of pre-pregnancy subclinical insulin resistance with cardiac dysfunction in healthy nulliparous women	3
First trimester screening (FTS) for placental pathology – Comparison of the efficacy of different methods	3

Diagnostic challenges of Thrombotic Microangiopathy (TMA) in a pregnant woman remote from term and a case report of atypical TTP	3
OP05_4. Umbilical cord plasma from women with pre-eclampsia reduces brain endothelial cell migration involving alterations in the VEGFR2-COFILIN-F-ACTIN polymerization pathway	3
PO2_06. Lymphatic mimicry of endothelial cells in utero-placental spiral arteries is impaired by overexpression of HSFLT1 in a murine model for preeclampsia	3
Hypertensive disorders of pregnancy in women with autoimmunity: A rising incidence?	3
Uterine artery doppler as prognostic indicator in Fetal growth restriction in third trimester	3
Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	2
PO2_10. CANCELLED: Maternal vascular malperfusion lesions and preeclampsia are associated with microvascular dysfunction, worse cognition and circulating angiogenic biomarkers 8-10 after pregnancy	2
OP09_1. Prepare: a stepped wedge cluster randomised trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia	2
Preeclampsia prediction with blood pressure measurements: A global external validation of the ALSPAC models	2
Cardiovascular remodelling and reverse remodelling during pregnancy and postpartum: Looking at the right side	2
Preeclampsia, gestational hypertension and incident dementia: A systematic review and meta-analysis of published evidence	2
Self-monitoring blood pressure in Pregnancy: Evaluation of health professional experiences of the BUMP trials	2
PO1_10. Incidence of prematurity in pregnancies complicated by hypertensive syndromes: A systematic review	2
P-072. Severe anemia and preeclampsia – Case report and literature review	2
New cardiac platform for the management of cardiovascular risk following preeclampsia using in vitro bioengineered cardiac spheroids and patient-derived stem cells	2
Bioprinting a placental model to study the effects of current and emerging treatments of preeclampsia	2
SSRI use in pregnancy: Moving towards collaborative, evidence-based decision-making	2
Relevance of maternal sodium level for preeclampsia-associated adverse pregnancy outcomes	2
OP07_4. Aspirin treatment improves reduced uterine perfusion pressure (RUPP)-induced cardiac dysfunction in pregnant rats	2
OP06_5. Alcohol exposure prior to pregnancy - does risk consumption increase the risk of preeclampsia and low birth weight? a swedish population-based cohort study	2
Incidence of essential hypertension but not echocardiographic abnormalities at four years with a history of preeclampsia with severe features	2
Retrospective study for classifying hypertensive disorders of pregnancy by time of onset	2
A tribute to Christopher Redman, MB, BChir, FRCP, FRCOG (ad eundum)	2
P-011. sFLT-1, PLGF e sFLT-1/PLGF levels in preeclampsia: correlation with mediated maternal results	2
Clinical manifestations and complications of preeclampsia and eclampsia in populations residing at high altitudes and very high altitudes: A scoping review	2
Racial differences in healthcare utilization among patients with suspected or diagnosed preeclampsia: A retrospective cohort study	2
PO9_07. CANCELLED : Grading the severity of early-onset preeclampsia using parameters considered for indication for delivery: a Delphi consensus	2
P-100. Retinal microvascular oxygen saturation in women 3 years after hypertensive disorders of pregnancy	2
O-010. Annual BMI gain is associated with the risk of HDP in the subsequent pregnancy	2
No association in maternal serum levels of TMAO and its precursors in pre-eclampsia and in non-complicated pregnancies	2
Self antenatal monitoring of blood pressure at home as interVention ( SAMBHAV) in hypertensive women: Challenges in the developing country	2
OP06_4. Circulating concentrations of glyxocalyx degradation products in preeclampsia	2
Diagnosis of placental insufficiency independently of clinical presentations using sFlt-1/PLGF ratio, including SGA patients	2
PO9_17. Interventions for improving subject enrollment in RCT	2
Blood pressure measurement and adverse pregnancy outcomes – Testing alternatives to 140/90 mmHg	2
The significance of mitochondrial haplogroups in preeclampsia risk	2
Letter to the editor: Caution: Not all sFlt-1/PlGF ratios are the same	2
PO1_11. Optimal timing of antenatal corticosteroid administration in pregnancies complicated by early-onset fetal growth restriction: The opticore study protocol	2
Title Page	2
Cardiovascular mortality risk a decade after twin and singleton pregnancies complicated by hypertensive disorders of pregnancy	2
Gestational weight gain among gravidae with hypertension receiving labetalol versus nifedipine	2
P085. Should we consider Hypertensive Disorders of Pregnancy a risk factor for postpartum haemorrhage?	2
SY8-1. Maternal diet and gut microbiota: effects on gut blood pressure and metabolism	2
Hypertension and diabetes risk in patients with previous pregnancy-related disorders and the time to onset of the disease	2
Association of fetal sex with angiogenic factors in normotensive and hypertensive pregnancy states	2
OP07_6. Hydroxychloroquine effect on endothelium – a role in the treatment of preeclampsia?	2
Role of chronic kidney disease and risk factors in preeclampsia	1
P-084. Symptomatic SARS-COV-2 infected pregnant patients and preeclampsia: worse outcome?	1
Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women	1
PO8_7. Short-chain fatty acid producing bacteria and butyrate levels are decreased in women who develop preeclampsia throughout gestation	1
Postpartum readmissions for hypertension in patients discharged on Labetalol and Nifedipine in a Tertiary Care Centre in South India	1
Healthcare providers’ knowledge of cardiovascular disease risk after preeclampsia: A pilot of five healthcare facilities in Lusaka, Zambia	1
Title Page	1
P-013. Negative predictive value of sFlt-1/PlGF ratio ≤ 38 for ruling out preeclampsia within 1–4 weeks of testing: A secondary analysis of the INSPIRE trial	1
P-046. Intensive blood pressure control in chronically hypertensive mice	1
P-083. Aortic Dissection during pregnancy: A case report	1
Preeclampsia biomarkers (sFlt-1/PlGF) dynamics are not disrupted by SARS-CoV-2 infection during pregnancy in a hypertensive disorder SARS-CoV-2 vaccinated cohort	1
Elevated expression of galectin-3, thioredoxin and thioredoxin interacting protein in preeclampsia	1
PO6_11. Clinical value and cost analysis of the SFLT-1/PLGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected preeclampsia: prepare cohort study	1
Sleep disordered breathing and the risk of severe maternal morbidity in women with preeclampsia: A population-based study	1
Reviewers	1
Y-007. Is the cut-off 38 the best value to predict adverse outcomes in pregnancies with abnormal uterine artery doppler In the second trimestre?	1
SY1-3. Trophoblast extracellular vesicles in preeclampsia	1
P-054. Maternal hemodynamics assessed by USCOM® device in patients with hypertensive disorders of pregnancy during peripartum	1
OP05_3. Time-of-disease risk prediction of adverse maternal outcomes of pre-eclampsia using artificial intelligence	1
sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19	1
P-082. A systematic review of cardiovascular disease prevention targeting lifestyle risk factors in women. Can the evidence inform post-partum health care after hypertensive disorders of pregnancy?	1
Blood pressure adjustments throughout healthy and hypertensive pregnancy: A systematic review and meta-analysis	1
Maternal C1q deficiency leads to impaired hemodynamic adaptations and cardiovascular dysfunction during pregnancy	1
O-007. Beneficial effect of Protease-activated receptor 2 (PAR2) on pregnancy	1
Y-019. Immunomodulatory effect of vitamin D on the activators of transcription and transcription factors of CD4+ T cell subsets in pregnant women with preeclampsia	1
P-076. Hypertensive disorder of pregnancy and gestational diabetes mellitus	1
P-057. Preeclampsia prediction based on urine peptidome study	1
GS-3. Prevention and prediction of preeclampsia	1
PO3_16. Use of magnesium sulfate in preeclampsia - main maternal side effects	1
PO1_07. Non proteinuric preeclampsia: Implications in the diagnosis and clinical and laboratory profile with 2013[StQuote]s new diagnostic criteria	1
P-007. Are there differences in the decidualizing endometrial secretome in women with recurrent pre-eclampsia?	1
WS-4. A multicenter prospective study of home blood pressure measurement during pregnancy in Japanese women	1
P-033. Changes of natural cytotoxicity receptors of CD56dim and CD56bright NK cells in peripheral blood and decidua in preeclampsia	1
P-095. Antithrombin gamma treatment in Japanese patients with early-onset severe preeclampsia: The study protocol of a randomized phase 3 trial (KOUNO-TORI)	1
The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice	1
P-080. A case of pheochromocytoma in pregnancy complicated with white coat hypertension	1
Elevated serum progesterone during in vitro fertilization treatment and the risk of ischemic placental disease	1
OP04_6. The risk of new-onset neurological disorders after pregnancy-induced hypertension; a nation-wide register-based cohort study	1
Editorial Board	1
Clinical study of fundoscopic findings in pregnancy induced hypertension	1
P-036. Early onset hypertensive disorders of pregnancy is a high risk phenotype for placental abruption: A Japanese nationwide cohort study	1
P-105. Probiotics supplementation increases the risk for preeclampsia	1
P-045. VEGFR/SFlt1 is associated to disruption of oxidative stress leading to endothelial dysfunction in preeclampsia	1
P-101. Pregnancy and infant outcomes for golimumab therapy for ulcerative colitis during the pregnancy and lactation periods: a retrospective report	1
Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction	1
Pre-Eclampsia in pregnancy: A Knowledge, Attitude and Practice (KAP) Survey amongst specialists, junior residents and Primary Care Providers (PCPs) in India	1
OP19_2. Luteolin, a natural flavonoid, attenuates the development of placental ischemia-induced hypertension in pregnant rats	1
O-006. Modulatory effect of two regimens of magnesium sulfate on the systemic inflammatory response in pregnant women with eclampsia or imminent eclampsia	1
SY9-3. Rheumatic diseases and HDP	1